We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Sinclair Pha | LSE:SPH | London | Ordinary Share | GB0033856740 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 31.80 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMSPH
Sinclair Pharma PLC
02 June 2016
Sinclair Pharma to Present at the Jefferies 2016 Healthcare Conference on 7(th) June
London, 2 June 2016 Sinclair Pharma plc (SPH.L), ("Sinclair" or the "Company") the international aesthetics company, today announces that Chris Spooner, Sinclair's Chief Executive Officer, will present at the Jefferies 2016 Healthcare Conference on Tuesday 7 June 2016, at 10:00 a.m. (EDT) in New York.
A copy of the slide presentation will be available through Sinclair's corporate website in the investor relations section from the morning of the presentation.
For further information, please contact:
Hot Features
Premium
Sinclair Pharma plc Tel: +44 (0) 20 7467
6920
Chris Spooner
Alan Olby
Peel Hunt LLP (NOMAD and Tel: +44 (0) 20 7418
Broker) 8900
James Steel
Oliver Jackson
FTI Consulting (Media enquiries) Tel: +44 (0) 203 727
1000
Ben Atwell
Brett Pollard
Notes to Editors:
About Sinclair Pharma plc
Sinclair Pharma plc is an international company operating in the fast growth, high gross margin, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. The Company is planning entry to multiple new geographic markets and line extension launches over the next few years. Sinclair has an established sales and marketing presence in the leading EU markets and Brazil, and a network of international distributors. For more information, please visit www.sinclairpharma.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRALLFVRRLILIIR
(END) Dow Jones Newswires
June 02, 2016 02:00 ET (06:00 GMT)
1 Year Sinclair Pharma Chart |
1 Month Sinclair Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
